Kilpatrick Townsend & Stockton LLP
Crystalline forms of 4-(tert-butoxyamino)-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazin-2-amine methanesulfonic acid salt
The invention discloses a crystal of 4-(tert-butoxyamino)-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazin-2-amine compound, a mesylate salt and crystal thereof, a preparation method thereof, a composition containing thereof, and a use thereof for inhibiting activity of mutant IDH2 and treating cancer.
Centaurus Biopharma Co., Ltd Lianyungang Runzhong Pharmaceutical Co., Ltd Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
A C C C
A61P C07B C07D C07C
inventional additional inventional inventional
Ticong Hongjiang Wei Rui Fei Jingli Huifeng Xiaojin
Huang Xu Wei Zhao Liu Wu Xiao Wang